Evidence map›Paper›PMID 38370106›Full record

ReviewThe Pan African medical journal2023

Providing information for decision-making in the Nigerian Polio Eradication Program, 2016-2020.

Tesfaye Erbeto, Philip Bammeke, Aron Aregay, Zabihullah Kamran, Ahmed Ibrahim, Nnamdi Usifoh, Usman Adamu, Bolu Omotayo, Fiona Braka, Eunice Damisa and 2 more

Abstract readReview
In one paragraph

Review in The Pan African medical journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Tesfaye ErbetoWorld Health Organization Country Office, Abuja, Nigeria.
Philip BammekeCenters for Disease Control and Prevention, Atlanta, Georgia, United States.
Aron AregayWorld Health Organization Country Office, Abuja, Nigeria.
Zabihullah KamranUnited Nations Children's Fund Nigeria Country Office, Copenhagen, Denmark.
Ahmed IbrahimWorld Health Organization Country Office, Abuja, Nigeria.
Nnamdi UsifohAfrican Field Epidemiology Network, Abuja, Nigeria.
Usman AdamuNational Primary Healthcare Development Agency, Abuja, Nigeria.
Bolu OmotayoCenters for Disease Control and Prevention, Atlanta, Georgia, United States.
Fiona BrakaWorld Health Organization Country Office, Abuja, Nigeria.
Eunice DamisaNational Primary Healthcare Development Agency, Abuja, Nigeria.
Walter KazadiWorld Health Organization Country Office, Abuja, Nigeria.
Faisal ShuaibNational Primary Healthcare Development Agency, Abuja, Nigeria.

Funding

World Health Organization 001
6 · The paper itself

Abstract

Nigeria made a coordinated effort to be certified by the World Health Organization's African Region for interrupting endemic transmission of wild poliovirus type-1 (WPV1) in August 2020 as a response to the resurgence of WPV1 cases in August 2016 after going two years without a case. The NEOC Data Working Group (DWG) was instrumental in providing quality and timely surveillance and campaign information for decision-making in order to interrupt WPV1 transmission and provide data toward documentation of its elimination for regional certification. The polio pre-campaign dashboard was used to assess the level of preparedness for Oral Poliovirus Vaccine (OPV) polio supplementary immunization activities (SIA) at three weeks, two weeks, one week, and three days to the start of each campaign implemented during 2016-2020. The administrative tally sheet, independent monitoring survey, and Lot Quality Assurance Sampling (LQAS) survey data collected and shared from the implementation level were analyzed by the EOC DWG to provide information by person, place, and time. Using a 90% threshold in LQAS surveys defining quality SIAs, the proportion of Local Government Areas (LGAs) in Nigeria's states in which post-SIA LQAS surveys were conducted that met this threshold were assessed over time. The highest level of preparedness attained by 3 days to a polio campaign during August 2016-February 2020 was 95% and the lowest attained was 77%. The admin, independent monitoring, and LQAS data analysis results were given to EOC working groups for assessing the performance and quality of each campaign. Twenty-twenty five percent of LGAs that failed LQAS were identified for repeat vaccination. Further, acute flaccid paralysis and environmental surveillance data and laboratory results were analyzed and shared with NEOC and partners. The government and partners used the information generated by the Data Working Group to take evidence-based action including determining the scope of the polio campaign, intensification of surveillance and routine immunization activities, and special intervention activities. On average, 12% of the 774 LGAs were identified as polio high risk LGAs for intervention using selected surveillance, routine immunization (RI), SIAs, and other relevant data sets. National Emergency Operation Centre Data Working Group provided quality and timely information that supported decision-making processes for the polio program in Nigeria. The quality and timely information enabled the NEOC to make evidence-based and timely decisions that contributed to gap identification and decision-making.

Indexed as

PoliomyelitisPoliovirusDisease EradicationHumansImmunization ProgramsLot Quality Assurance SamplingNigeriaPoliovirus Vaccine, OralPoliovirus Vaccine, Oraldashboarddecision-makinginformationlocal government areasmonitoringpoliosurveillanceVaccination campaign

Identifiers

PMID38370106
PMCPMC10874091

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.